Wednesday January 7, 2:44 pm Eastern Time

Trinity Biotech Gets FDA Okay to Market Adenovirus Test Kit

Jan. 7, 1998, Trinity Biotech plc (Nasdaq: TRIBY) said it received clearance from the Food and Drug Administration to market the company's Adenovirus test kit.

The company said the test is an enzyme immunoassay in microtitre plate format, which detects the presence of the Adenovirus in stool samples.

TRIBY said the product will be distributed in the U.S. by Wampole Laboratories, a division of Carter Wallace Inc. (NYSE:CAR ).

Back to Press Releases